Prospective comparison of the effects of maxacalcitol and calcitriol in chronic hemodialysis patients with secondary hyperparathyroidism: a multicenter, randomized crossover study.

Mochizuki, T; Naganuma, S; Tanaka, Y; Iwamoto, Y; Ishiguro, C; Kawashima, Y; Maekawa, K; Suda, A; Akiba, T

Mochizuki, T; Naganuma, S; Tanaka, Y; Iwamoto, Y; Ishiguro, C; Kawashima, Y; Maekawa, K; Suda, A; Akiba, T.

Affiliation

Mochizuki T; Department of Nephrology, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan. tmochizuki@kameda.jp

Clin Nephrol ; 67(1): 12-9, 2007 Jan.

Article in En | MEDLINE | ID: mdl-17269594

Subject(s)

Calcitriol/analogs & derivatives; Calcitriol/therapeutic use; Hyperparathyroidism, Secondary/drug therapy; Renal Dialysis; Vitamin D/analogs & derivatives; Aged; Calcium/blood; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary/blood; Hyperparathyroidism, Secondary/etiology; Male; Middle Aged; Parathyroid Hormone/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vitamin D / Calcitriol / Renal Dialysis / Hyperparathyroidism, Secondary Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2007 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links